ME/CFS AUSTRALIA (SA) INC Registered Charity 698 Mailing address: GPO Box 383, Adelaide, South Australia 5001 Office: 266 Port Road, Hindmarsh, South Australia 5007 Ph: (08) 8346 3237 ('834 MECFS') Office Hours: Wednesdays, 10am-3pm Support Line: (Mondays and Thursdays, 10am-3pm) Ph: (08) 8346 3237 SA country callers: Ph: 1300 128 339 (local call)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
Disclaimer ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||||
Phoenix Rising: March/April 2007 issueThursday 7 June 2007
You can subscribe to the newsletter as well as download each issue. The March/April 2007 issue has been published and is now available for download:
Here is Cort Johnson’s introduction to the issue: Welcome to the March/April Edition of Phoenix Rising. This edition explores the intriguing connections between CFS and other cognitively challenging and fatiguing disorders such as multiple sclerosis, post-cancer, fibromyalgia and others. Interest in the subset of highly fatigued MS, cancer and other patients has risen greatly over the past five years. Are the researchers studying highly fatigued MS patients uncovering the same disease processes that occcur in CFS? Are Fibromyalgia and CFS distinct diseases or close cousins? These are some of the questions this edition examines. You can access the newsletter at the following URL: http://phoenix-cfs.org/PR%20II%20V%20VI.htm, or the attached PDF file [see above]. Coming up shortly will be a Report From Lobby Day and we’ll take a look at the outcome of the ‘big’ NIH effort on CFS and what it tells us about the state of CFS research in that institution. Cort. |
||||||||||||||